HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Durable Response to Immune Checkpoint Blockade in a Platinum-Refractory Patient With Nonseminomatous Germ Cell Tumor.

AuthorsEthan A Chi, Michael T Schweizer
JournalClinical genitourinary cancer (Clin Genitourin Cancer) Vol. 15 Issue 5 Pg. e855-e857 (10 2017) ISSN: 1938-0682 [Electronic] United States
PMID28465048 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Nivolumab
  • Podophyllotoxin
  • Cisplatin
  • Ifosfamide
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cisplatin (therapeutic use)
  • Humans
  • Ifosfamide (therapeutic use)
  • Male
  • Neoplasm Metastasis
  • Neoplasms, Germ Cell and Embryonal (diagnostic imaging, drug therapy, immunology)
  • Nivolumab
  • Off-Label Use
  • Podophyllotoxin (therapeutic use)
  • Testicular Neoplasms (diagnostic imaging, drug therapy, immunology)
  • Treatment Outcome
  • Watchful Waiting

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: